Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039816 | SCV000063507 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | 177+11G>A in Intron 01 of BSND: This variant is not expected to have clinical si gnificance because it is not located within the conserved splice consensus seque nce and has been identified in 14.5% (543/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.was hington.edu/EVS; dbSNP rs78904893). |
Prevention |
RCV000039816 | SCV000315323 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000039816 | SCV000341558 | benign | not specified | 2016-04-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000350902 | SCV000358180 | benign | Bartter disease type 4A | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV001534820 | SCV001751784 | benign | not provided | 2018-07-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000350902 | SCV001754912 | benign | Bartter disease type 4A | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001534820 | SCV002488912 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001534820 | SCV005286608 | benign | not provided | criteria provided, single submitter | not provided |